Literature DB >> 19576220

Structural reorganization of alpha-synuclein at low pH observed by NMR and REMD simulations.

Kuen-Phon Wu1, Daniel S Weinstock, Chitra Narayanan, Ronald M Levy, Jean Baum.   

Abstract

alpha-Synuclein is an intrinsically disordered protein that appears in aggregated forms in the brains of patients with Parkinson's disease. The conversion from monomer to aggregate is complex, and aggregation rates are sensitive to changes in amino acid sequence and environmental conditions. It has previously been observed that alpha-synuclein aggregates faster at low pH than at neutral pH. Here, we combine NMR spectroscopy and molecular simulations to characterize alpha-synuclein conformational ensembles at both neutral and low pH in order to understand how the altered charge distribution at low pH changes the structural properties of these ensembles and leads to an increase in aggregation rate. The N-terminus, which has a small positive charge at neutral pH due to a balance of positively and negatively charged amino acid residues, is very positively charged at low pH. Conversely, the acidic C-terminus is highly negatively charged at neutral pH and becomes essentially neutral and hydrophobic at low pH. Our NMR experiments and replica exchange molecular dynamics simulations indicate that there is a significant structural reorganization within the low-pH ensemble relative to that at neutral pH in terms of long-range contacts, hydrodynamic radius, and the amount of heterogeneity within the conformational ensembles. At neutral pH, there is a very heterogeneous ensemble with transient contacts between the N-terminus and the non-amyloid beta component (NAC); however, at low pH, there is a more homogeneous ensemble that exhibits strong contacts between the NAC and the C-terminus. At both pH values, transient contacts between the N- and C-termini are observed, the NAC region shows similar exposure to solvent, and the entire protein shows similar propensities to secondary structure. Based on the comparison of the neutral- and low-pH conformational ensembles, we propose that exposure of the NAC region to solvent and the secondary-structure propensity are not factors that account for differences in propensity to aggregate in this context. Instead, the comparison of the neutral- and low-pH ensembles suggests that the change in long-range interactions between the low- and neutral-pH ensembles, the compaction of the C-terminal region at low pH, and the uneven distribution of charges across the sequence are key to faster aggregation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576220      PMCID: PMC2766395          DOI: 10.1016/j.jmb.2009.06.063

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  67 in total

Review 1.  Protein misfolding, evolution and disease.

Authors:  C M Dobson
Journal:  Trends Biochem Sci       Date:  1999-09       Impact factor: 13.807

Review 2.  Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease.

Authors:  P T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.

Authors:  Wolfgang Hoyer; Dmitry Cherny; Vinod Subramaniam; Thomas M Jovin
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

4.  The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils.

Authors:  O M El-Agnaf; A M Bodles; D J Guthrie; P Harriott; G B Irvine
Journal:  Eur J Biochem       Date:  1998-11-15

5.  Role of alpha-synuclein in presynaptic dopamine recruitment.

Authors:  Leonid Yavich; Heikki Tanila; Saila Vepsäläinen; Pekka Jäkälä
Journal:  J Neurosci       Date:  2004-12-08       Impact factor: 6.167

6.  alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.

Authors:  S J Wood; J Wypych; S Steavenson; J C Louis; M Citron; A L Biere
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

Review 7.  Glutamine repeats and neurodegenerative diseases: molecular aspects.

Authors:  M F Perutz
Journal:  Trends Biochem Sci       Date:  1999-02       Impact factor: 13.807

8.  Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.

Authors:  W S Davidson; A Jonas; D F Clayton; J M George
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

9.  Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.

Authors:  J M Jenco; A Rawlingson; B Daniels; A J Morris
Journal:  Biochemistry       Date:  1998-04-07       Impact factor: 3.162

10.  Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations.

Authors:  Matthew M Dedmon; Kresten Lindorff-Larsen; John Christodoulou; Michele Vendruscolo; Christopher M Dobson
Journal:  J Am Chem Soc       Date:  2005-01-19       Impact factor: 15.419

View more
  70 in total

1.  Sequence determinants of compaction in intrinsically disordered proteins.

Authors:  Joseph A Marsh; Julie D Forman-Kay
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

2.  Protein alignment using cellulose nanocrystals: practical considerations and range of application.

Authors:  Alexey Y Denisov; Elisabeth Kloser; Derek G Gray; Anthony K Mittermaier
Journal:  J Biomol NMR       Date:  2010-05-12       Impact factor: 2.835

Review 3.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

4.  Transient β-hairpin formation in α-synuclein monomer revealed by coarse-grained molecular dynamics simulation.

Authors:  Hang Yu; Wei Han; Wen Ma; Klaus Schulten
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

5.  NMR determination of pKa values in α-synuclein.

Authors:  Robyn L Croke; Sharadrao M Patil; Jason Quevreaux; Debra A Kendall; Andrei T Alexandrescu
Journal:  Protein Sci       Date:  2010-12-13       Impact factor: 6.725

6.  α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.

Authors:  Bruno Fauvet; Martial K Mbefo; Mohamed-Bilal Fares; Carole Desobry; Sarah Michael; Mustafa T Ardah; Elpida Tsika; Philippe Coune; Michel Prudent; Niels Lion; David Eliezer; Darren J Moore; Bernard Schneider; Patrick Aebischer; Omar M El-Agnaf; Eliezer Masliah; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

7.  A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.

Authors:  Gina M Moriarty; Michael P Olson; Tamr B Atieh; Maria K Janowska; Sagar D Khare; Jean Baum
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

Review 8.  Exploring the accessible conformations of N-terminal acetylated α-synuclein.

Authors:  Gina M Moriarty; Maria K Janowska; Lijuan Kang; Jean Baum
Journal:  FEBS Lett       Date:  2013-03-13       Impact factor: 4.124

Review 9.  A flash in the pan: dissecting dynamic amyloid intermediates using fluorescence.

Authors:  Abhinav Nath; Elizabeth Rhoades
Journal:  FEBS Lett       Date:  2013-03-01       Impact factor: 4.124

Review 10.  Interactions between the Intrinsically Disordered Proteins β-Synuclein and α-Synuclein.

Authors:  Jonathan K Williams; Xue Yang; Jean Baum
Journal:  Proteomics       Date:  2018-09-09       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.